spacer
home > > spring 2004 > in dear diary... a comparison of clinical collection tools
PUBLICATIONS


In Dear Diary... A Comparison of Clinical Collection Tools

Diaries and journals have been popular throughout history. From children to the elderly, people have used this very powerful - and private - means of self-expression to put their innermost thoughts and feelings down on paper; some for catharsis and others for posterity. Those of Marie Curie (radioactivity), Jonas Salk (Polio vaccine) and James Watson and Francis Crick (DNA), among others, have improved and extended the very existence of mankind. When making their first diary entry, however, it is unlikely that any of them knew it would potentially revolutionise their world or that of their progeny. The same holds true today within the realm of pharmaceutical research.

Today, many pharmaceutical and biotech companies utilise various forms of patient diaries in their clinical drug studies as a means of collecting invaluable endpoint data needed to bring new drugs to market more quickly, while ensuring the drugs' efficacy and overall safety to humans. However, it takes many people and a multitude of diary entries to achieve that end result.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Kris Gustafson, Vice President of Interactive Technologies and Ashley B Threinen, IVRS Project Manager at ICON Clinical Research

Kris Gustafson is Vice President of Interactive Technologies for ICON Clinical Research. He has developed hundreds of interactive voice response and web systems for clinical trials in the past 10 years. In his current management role, Kris continues to improve processes while adapting new technology to provide excellence in all trial management solutions.

Ashley B Threinen MA, is an IVRS Project Manager with ICON Clinical Research. She has been involved in clinical pharmaceutical research for more than four years and has more than 10 years' experience as a mental health counsellor. Ashley is also a well-published science writer and magazine editor.
spacer
Kris Gustafson
spacer
spacer
spacer
Ashley B Threinen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cognizant Shared Investigator Platform for Life Sciences Reaches Major Milestone in Accelerating Drug Discovery

Cognizant (Nasdaq: CTSH) announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution, has reached a new milestone of over 100,000 users in 84 countries. The platform has become increasingly critical to progressing clinical trials as prevailing social distancing norms have significantly curtailed in-person collaboration.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement